Cargando…

Cardiovascular Assessment Tool for Breast Cancer Survivors and Oncology Providers: Usability Study

BACKGROUND: Cardiovascular health is of increasing concern to breast cancer survivors and their health care providers, as many survivors are more likely to die from cardiovascular disease than cancer. Implementing clinical decision support tools to address cardiovascular risk factor awareness in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Weaver, Kathryn E, Klepin, Heidi D, Wells, Brian J, Dressler, Emily V, Winkfield, Karen M, Lamar, Zanetta S, Avery, Tiffany P, Pajewski, Nicholas M, Hundley, W Gregory, Johnson, Aimee, Davidson, Eleanor C, Lopetegui, Marcelo, Foraker, Randi E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861995/
https://www.ncbi.nlm.nih.gov/pubmed/33475511
http://dx.doi.org/10.2196/18396
_version_ 1783647191829577728
author Weaver, Kathryn E
Klepin, Heidi D
Wells, Brian J
Dressler, Emily V
Winkfield, Karen M
Lamar, Zanetta S
Avery, Tiffany P
Pajewski, Nicholas M
Hundley, W Gregory
Johnson, Aimee
Davidson, Eleanor C
Lopetegui, Marcelo
Foraker, Randi E
author_facet Weaver, Kathryn E
Klepin, Heidi D
Wells, Brian J
Dressler, Emily V
Winkfield, Karen M
Lamar, Zanetta S
Avery, Tiffany P
Pajewski, Nicholas M
Hundley, W Gregory
Johnson, Aimee
Davidson, Eleanor C
Lopetegui, Marcelo
Foraker, Randi E
author_sort Weaver, Kathryn E
collection PubMed
description BACKGROUND: Cardiovascular health is of increasing concern to breast cancer survivors and their health care providers, as many survivors are more likely to die from cardiovascular disease than cancer. Implementing clinical decision support tools to address cardiovascular risk factor awareness in the oncology setting may enhance survivors’ attainment or maintenance of cardiovascular health. OBJECTIVE: We sought to evaluate survivors’ awareness of cardiovascular risk factors and examine the usability of a novel electronic health record enabled cardiovascular health tool from the perspective of both breast cancer survivors and oncology providers. METHODS: Breast cancer survivors (n=49) recruited from a survivorship clinic interacted with the cardiovascular health tool and completed pre and posttool assessments about cardiovascular health knowledge and perceptions of the tool. Oncologists, physician assistants, and nurse practitioners (n=20) who provide care to survivors also viewed the cardiovascular health tool and completed assessments of perceived usability and acceptability. RESULTS: Enrolled breast cancer survivors (84% White race, 4% Hispanic ethnicity) had been diagnosed 10.8 years ago (SD 6.0) with American Joint Committee on Cancer stage 0, I, or II (45/49, 92%). Prior to viewing the tool, 65% of survivors (32/49) reported not knowing their level for one or more cardiovascular health factors (range 0-4). On average, only 45% (range 0%-86%) of survivors’ known cardiovascular health factors were at an ideal level. More than 50% of survivors had ideal smoking status (45/48, 94%) or blood glucose level (29/45, 64%); meanwhile, less than 50% had ideal blood pressure (12/49, 24%), body mass index (12/49, 24%), cholesterol level (17/35, 49%), diet (7/49, 14%), and physical activity (10/49. 20%). More than 90% of survivors thought the tool was easy to understand (46/47, 98%), improved their understanding (43/47, 91%), and was helpful (45/47, 96%); overall, 94% (44/47 survivors) liked the tool. A majority of survivors (44/47, 94%) thought oncologists should discuss cardiovascular health during survivorship care. Most (12/20, 60%) oncology providers (female: 12/20, 60%; physicians: 14/20, 70%) had been practicing for more than 5 years. Most providers agreed the tool provided useful information (18/20, 90%), would help their effectiveness (18/20, 90%), was easy to use (20/20, 100%), and presented information in a useful format (19/20, 95%); and 85% of providers (17/20) reported they would use the tool most or all of the time when providing survivorship care. CONCLUSIONS: These usability data demonstrate acceptability of a cardiovascular health clinical decision support tool in oncology practices. Oncology providers and breast cancer survivors would likely value the integration of such apps in survivorship care. By increasing awareness and communication regarding cardiovascular health, electronic health record–enabled tools may improve survivorship care delivery for breast cancer and ultimately patient outcomes.
format Online
Article
Text
id pubmed-7861995
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-78619952021-02-10 Cardiovascular Assessment Tool for Breast Cancer Survivors and Oncology Providers: Usability Study Weaver, Kathryn E Klepin, Heidi D Wells, Brian J Dressler, Emily V Winkfield, Karen M Lamar, Zanetta S Avery, Tiffany P Pajewski, Nicholas M Hundley, W Gregory Johnson, Aimee Davidson, Eleanor C Lopetegui, Marcelo Foraker, Randi E JMIR Cancer Original Paper BACKGROUND: Cardiovascular health is of increasing concern to breast cancer survivors and their health care providers, as many survivors are more likely to die from cardiovascular disease than cancer. Implementing clinical decision support tools to address cardiovascular risk factor awareness in the oncology setting may enhance survivors’ attainment or maintenance of cardiovascular health. OBJECTIVE: We sought to evaluate survivors’ awareness of cardiovascular risk factors and examine the usability of a novel electronic health record enabled cardiovascular health tool from the perspective of both breast cancer survivors and oncology providers. METHODS: Breast cancer survivors (n=49) recruited from a survivorship clinic interacted with the cardiovascular health tool and completed pre and posttool assessments about cardiovascular health knowledge and perceptions of the tool. Oncologists, physician assistants, and nurse practitioners (n=20) who provide care to survivors also viewed the cardiovascular health tool and completed assessments of perceived usability and acceptability. RESULTS: Enrolled breast cancer survivors (84% White race, 4% Hispanic ethnicity) had been diagnosed 10.8 years ago (SD 6.0) with American Joint Committee on Cancer stage 0, I, or II (45/49, 92%). Prior to viewing the tool, 65% of survivors (32/49) reported not knowing their level for one or more cardiovascular health factors (range 0-4). On average, only 45% (range 0%-86%) of survivors’ known cardiovascular health factors were at an ideal level. More than 50% of survivors had ideal smoking status (45/48, 94%) or blood glucose level (29/45, 64%); meanwhile, less than 50% had ideal blood pressure (12/49, 24%), body mass index (12/49, 24%), cholesterol level (17/35, 49%), diet (7/49, 14%), and physical activity (10/49. 20%). More than 90% of survivors thought the tool was easy to understand (46/47, 98%), improved their understanding (43/47, 91%), and was helpful (45/47, 96%); overall, 94% (44/47 survivors) liked the tool. A majority of survivors (44/47, 94%) thought oncologists should discuss cardiovascular health during survivorship care. Most (12/20, 60%) oncology providers (female: 12/20, 60%; physicians: 14/20, 70%) had been practicing for more than 5 years. Most providers agreed the tool provided useful information (18/20, 90%), would help their effectiveness (18/20, 90%), was easy to use (20/20, 100%), and presented information in a useful format (19/20, 95%); and 85% of providers (17/20) reported they would use the tool most or all of the time when providing survivorship care. CONCLUSIONS: These usability data demonstrate acceptability of a cardiovascular health clinical decision support tool in oncology practices. Oncology providers and breast cancer survivors would likely value the integration of such apps in survivorship care. By increasing awareness and communication regarding cardiovascular health, electronic health record–enabled tools may improve survivorship care delivery for breast cancer and ultimately patient outcomes. JMIR Publications 2021-01-21 /pmc/articles/PMC7861995/ /pubmed/33475511 http://dx.doi.org/10.2196/18396 Text en ©Kathryn E Weaver, Heidi D Klepin, Brian J Wells, Emily V Dressler, Karen M Winkfield, Zanetta S Lamar, Tiffany P Avery, Nicholas M Pajewski, W Gregory Hundley, Aimee Johnson, Eleanor C Davidson, Marcelo Lopetegui, Randi E Foraker. Originally published in JMIR Cancer (http://cancer.jmir.org), 21.01.2021. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Cancer, is properly cited. The complete bibliographic information, a link to the original publication on http://cancer.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Weaver, Kathryn E
Klepin, Heidi D
Wells, Brian J
Dressler, Emily V
Winkfield, Karen M
Lamar, Zanetta S
Avery, Tiffany P
Pajewski, Nicholas M
Hundley, W Gregory
Johnson, Aimee
Davidson, Eleanor C
Lopetegui, Marcelo
Foraker, Randi E
Cardiovascular Assessment Tool for Breast Cancer Survivors and Oncology Providers: Usability Study
title Cardiovascular Assessment Tool for Breast Cancer Survivors and Oncology Providers: Usability Study
title_full Cardiovascular Assessment Tool for Breast Cancer Survivors and Oncology Providers: Usability Study
title_fullStr Cardiovascular Assessment Tool for Breast Cancer Survivors and Oncology Providers: Usability Study
title_full_unstemmed Cardiovascular Assessment Tool for Breast Cancer Survivors and Oncology Providers: Usability Study
title_short Cardiovascular Assessment Tool for Breast Cancer Survivors and Oncology Providers: Usability Study
title_sort cardiovascular assessment tool for breast cancer survivors and oncology providers: usability study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861995/
https://www.ncbi.nlm.nih.gov/pubmed/33475511
http://dx.doi.org/10.2196/18396
work_keys_str_mv AT weaverkathryne cardiovascularassessmenttoolforbreastcancersurvivorsandoncologyprovidersusabilitystudy
AT klepinheidid cardiovascularassessmenttoolforbreastcancersurvivorsandoncologyprovidersusabilitystudy
AT wellsbrianj cardiovascularassessmenttoolforbreastcancersurvivorsandoncologyprovidersusabilitystudy
AT dressleremilyv cardiovascularassessmenttoolforbreastcancersurvivorsandoncologyprovidersusabilitystudy
AT winkfieldkarenm cardiovascularassessmenttoolforbreastcancersurvivorsandoncologyprovidersusabilitystudy
AT lamarzanettas cardiovascularassessmenttoolforbreastcancersurvivorsandoncologyprovidersusabilitystudy
AT averytiffanyp cardiovascularassessmenttoolforbreastcancersurvivorsandoncologyprovidersusabilitystudy
AT pajewskinicholasm cardiovascularassessmenttoolforbreastcancersurvivorsandoncologyprovidersusabilitystudy
AT hundleywgregory cardiovascularassessmenttoolforbreastcancersurvivorsandoncologyprovidersusabilitystudy
AT johnsonaimee cardiovascularassessmenttoolforbreastcancersurvivorsandoncologyprovidersusabilitystudy
AT davidsoneleanorc cardiovascularassessmenttoolforbreastcancersurvivorsandoncologyprovidersusabilitystudy
AT lopeteguimarcelo cardiovascularassessmenttoolforbreastcancersurvivorsandoncologyprovidersusabilitystudy
AT forakerrandie cardiovascularassessmenttoolforbreastcancersurvivorsandoncologyprovidersusabilitystudy